Aqueous liquid pharmaceutical composition comprising a) almotriptan and b) at least one compound selected from i) 1-methyl-5-((pyrrolidin-1-ylsulfonyl)methyl)spiro[indoline-3,3-pyrrolidin]-2-ol, and ii) 3-(2-(dimethylamino)ethyl)-5-((pyrrolidin-1-ylsulfonyl)methyl)-1 H-indol-2-ol.a) 알모트립탄 및 b) 하기로부터 선택된 화합물 하나 이상을 포함하는 수성 액체 약학적 조성물:i) 1-메틸-5-((피롤리딘-1-일술포닐)메틸)스피로[인돌린-3,3-피롤리딘]-2-올,및ii) 3-(2-(디메틸아미노)에틸)-5-((피롤리딘-1-일술포닐)메틸)-1H-인돌-2-올.